Modified t-PA with kringle-/replaced by another kringle

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9463, 435226, 4352402, 4352523, 4353201, 435217, 435214, 536 27, 530324, A61K 37547, C12N 964, C12N 1558, C07H 2104

Patent

active

051495333

ABSTRACT:
Tissue plasminogen activator analogs exhibiting greater specificity for fibrin than native t-PA are disclosed. The analogs include the K1 domain of native t-PA replaced with another kringle domain mediating the binding of the analog to fibrin. The kringle contains six cysteine residues. The t-PA analogs may further include a variety of substitutions and modifications. Pharmaceutical compositions containing one or more of the t-PA analogs along with a physiologically acceptable carrier or diluent are also disclosed.

REFERENCES:
patent: 4766075 (1988-08-01), Goeddel et al.
Pennica et al., "Cloning and Expression of Human Tissue-type Plasminogen Activator cDNA in E. coli", Nature 301:214-221, 1983.
Degan et al., "Characterization of the Complementary Deoxyribonucleic Acid and Gene Coding for Human Prothrombin", Biochemistry 22:2087-2097, 1983.
Banyai et al., "Common Evolutionary Origin of the Fibrin-binding Structures of Fibronectin and Tissue-type Plasminogen Activator", FEBS Lett. 163:37-41, 1983.
Vali and Patthy, "The Fibrin-binding Site of Human Plasminogen", J. Biol. Chem. 259:13690-13694, 1984.
Wang et al., "Site-Specific Mutagenesis of Human Interleukin-2 Gene: Structure-Function Analysis of the Cysteine Residues", Science 224:1431-1433, 1984.
van Zonneveld et al., "On the Relation Between Structure and Function of Human Tissue-type Plasminogen Activator", Throm. Haemostas. 54:4,1985.
Kagitani et al., "Expression in E. coli of Finger-domain Lacking Tissue-type Plasminogen Activator with High Fibrin Affinity", FEBS Lett. 189:145-149, 1985.
van Zonneveld et al., "On the Interaction of the Finger and the Kringle-2 Domain of Tissue-type Plasminogen Activator with Fibrin", J. Biol. Chem 261:14214-14218, 1986.
Forsgren et al., "Molecular Cloning and Characterization of a Full-length cDNA Clone for Human Plasminogen", FEBS Lett. 213:254-260, 1987.
Verstraete et al., Blood, vol. 67, No. 6, pp. 1529-1541, Jun., 1986.
van Zonneveld et al., Proc. Natl. Acad. Sci., vol. 83, pp. 4670-4674, Jul., 1986.
De Marco et al., J. Biol. Chem, vol. 257, pp. 12716-12721, 1982.
Suggs et al., Proc. Natl. Acad Sci., vol. 78, pp. 6613-6617, 1981.
Malinowski et al., Biochemistry, vol. 23, pp. 4243-4250, 1984.
McMullen et al., J. Biol. Chem, vol. 260, pp. 5323-5341, 1985.
Collen, "On the Regulation and Control of Fibrinolysis", Throm. Haemostas. 43:77-89, 1980.
Hoylaerts et al., "Kinetics of the Activation of Plasminogen by Human Tissue Plasminogen Activator", J. Biol. Chem. 257:2912-2919, 1982.
Edlund et al., "Isolation of cDNA Sequences Coding for a Part of Human Tissue Plasminogen Activator", Proc. Natl. Acad. Sci. USA 80:349-352, 1983.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified t-PA with kringle-/replaced by another kringle does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified t-PA with kringle-/replaced by another kringle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified t-PA with kringle-/replaced by another kringle will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1067073

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.